Website
N/ATelephone
61.7.3152.3200
Address
Suite 302, Level 3 9 Sherwood Road Toowong Tower Toowong, Queensland (QLD) 4066
Description
Anteris Technologies Ltd. is a structural heart company, which engages in research, develops, commercializes, and distributes medical technologies and devices. It operates through the following geographical segments: Australia, United States, and Switzerland. It manufactures, distributes, and sells ADAPT and DurAVR regenerative tissue products, and researches and develops regenerative medicine and immunotherapies. The company was founded on June 23, 1999 and is headquartered in Toowong, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 8.5 - 23.93
Trade Value (12mth)
AU$76,595.00
1 week
-14.23%
1 month
-1.95%
YTD
-52.42%
1 year
-53.16%
All time high
186.88
EPS 3 yr Growth
67.00%
EBITDA Margin
%
Operating Cashflow
-$51m
Free Cash Flow Return
-234.70%
ROIC
-307.30%
Interest Coverage
-160.10
Quick Ratio
2.50
Shares on Issue (Fully Dilluted)
18m
HALO Sector
Healthcare
Next Company Report Date
27-Feb-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
20 December 24 |
Daily Stabilisation Activity Report - 19 December 2024
×
Daily Stabilisation Activity Report - 19 December 2024 |
19 December 24 |
Daily Stabilisation Activity Report - 18 December 2024
×
Daily Stabilisation Activity Report - 18 December 2024 |
18 December 24 |
Daily Stabilisation Activity Report - 17 December 2024
×
Daily Stabilisation Activity Report - 17 December 2024 |
17 December 24 |
Reinstatement to Quotation
×
Reinstatement to Quotation |
17 December 24 |
Daily Stabilisation Activity Report - 16 December 2024
×
Daily Stabilisation Activity Report - 16 December 2024 |
17 December 24 |
Closing of US IPO, NASDAQ listing, ASX Listing of CDIs
×
Closing of US IPO, NASDAQ listing, ASX Listing of CDIs |
17 December 24 |
Cleansing Notice
×
Cleansing Notice |
17 December 24 |
SEC Form S-8 Registration Statement filing
×
SEC Form S-8 Registration Statement filing |
17 December 24 |
SEC Form 8-K filing, Scheme implementation matters
×
SEC Form 8-K filing, Scheme implementation matters |
16 December 24 |
Admission and Commencement of Quotation
×
Admission and Commencement of Quotation |
16 December 24 |
Appendix 1A
×
Appendix 1A |
16 December 24 |
Information Form and Checklist
×
Information Form and Checklist |
16 December 24 |
Information Form and Checklist Annexure 3
×
Information Form and Checklist Annexure 3 |
16 December 24 |
Scheme Booklet
×
Scheme Booklet |
16 December 24 |
Supplementary Scheme Booklet
×
Supplementary Scheme Booklet |
16 December 24 |
Amended and Restated Bylaws
×
Amended and Restated Bylaws |
16 December 24 |
Trading Policy
×
Trading Policy |
16 December 24 |
Corporate Governance Statement
×
Corporate Governance Statement |
16 December 24 |
Equity Incentive Plan
×
Equity Incentive Plan |
16 December 24 |
Pre-Quotation Disclosure
×
Pre-Quotation Disclosure |
16 December 24 |
Daily Stabilisation Activity Report - 13 December 2024
×
Daily Stabilisation Activity Report - 13 December 2024 |
16 December 24 |
IPO Roadshow Presentation
×
IPO Roadshow Presentation |
16 December 24 |
ATGC Final Prospectus
×
ATGC Final Prospectus |
16 December 24 |
Implementation of the Schemes
×
Implementation of the Schemes |
13 December 24 |
Confirmation of Implementation Timetable
×
Confirmation of Implementation Timetable |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.